Join BNMS | Print Page | Contact Us | Sign In
News & Press: Latest News

NICE Guideline Includes 99mTc-Sestamibi SPECT/CT in Kidney Cancer Imaging Pathway

4 hours ago   (0 Comments)
Posted by: Caroline Oxley
The recent publication of the National Institute for Health and Care Excellence (NICE) guideline Kidney cancer: diagnosis and management (NG256) includes recommendations relating to the use of 99mTc-sestamibi SPECT/CT in selected patients with indeterminate renal lesions.
The guideline recommends considering 99mTc-sestamibi SPECT/CT following multiphasic CT or MRI where increased confidence that a lesion is oncocytic (including oncocytoma or chromophobe renal cell carcinoma) would change management, particularly where biopsy is not possible or is declined by the patient.
For many BNMS members, this represents a positive recognition of the contribution that nuclear medicine can make within multidisciplinary uro-oncology services and highlights an emerging area of clinical practice where departments may increasingly be asked to support local pathways.
As interest in renal sestamibi SPECT/CT develops, nuclear medicine departments may wish to review local expertise, imaging protocols and service availability, and engage with local urology and radiology colleagues regarding potential referral pathways and future service requirements.
The British Nuclear Medicine Society (BNMS) remains committed to supporting members through education, dissemination of best practice, and collaboration with relevant stakeholders as experience in this area develops. We would welcome hearing from members who are already providing renal sestamibi SPECT/CT services, as well as departments interested in developing local pathways or sharing experience.
If you have suggestions on how BNMS can support service development, education or collaboration in this area, please get in touch.
The full NICE guideline, Kidney cancer: diagnosis and management (NG256), is available here:
https://www.nice.org.uk/guidance/ng256

« Back to Index

 

 

© 2013 BNMS unless otherwise stated.
The BNMS is a registered as a company in England and Wales with number 08082786.  The BNMS is a charity governed by the rules of the Charity Commission for England and Wales - Registered Number 1150234.  Registered Office: The Royal College of Physicians, 11 St. Andrew's Place, Regent's Park, London NW1 4LE.
The British Nuclear Medicine Society is not able to give specific clinical advice to members of the public. If you are concerned about your scan or therapy please seek the opinion of a nuclear medicine clinician where you were seen or the clinician who referred you to the department or your GP.
Enquiries related to issues such as internships and work experience opportunities, should be directed to the relevant professional body e.g., for radiologists, this will be the Royal College of Radiologists.